Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vmijam-MD4 Tablet

Prescription Icon
Prescription Required

Marketer

Jamrex Biotech Pvt Ltd

Salt Composition

Ondansetron (4mg)

Overview Vmijam-MD4 Tablet

Navir-4 tablets are prescribed to alleviate nausea and vomiting stemming from various medical issues, such as indigestion. They are also employed prophylactically against nausea and vomiting triggered by surgical procedures, cancer treatments (chemotherapy or radiotherapy). Navir-4 may be administered independently or in conjunction with other medications, with or without food. Dosage is determined by your physician based on the underlying condition. The initial dose is typically administered prior to surgery, chemotherapy, or radiotherapy; subsequent doses, if prescribed, are usually limited to a few days post-treatment. Consistent daily dosing at the same time(s) optimizes efficacy. Avoid exceeding the recommended dosage. This medication does not address other side effects associated with cancer therapies and is ineffective against motion sickness-induced vomiting. Common side effects include headaches, altered bowel habits (diarrhea or constipation), and fatigue; these usually resolve upon cessation of treatment. Persistent or troublesome side effects warrant consultation with your doctor, who may offer mitigating strategies. Prior to commencing treatment, inform your physician of any pre-existing heart or liver conditions, gastrointestinal obstructions, and all other medications you are taking, particularly those for epilepsy, heart conditions, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should seek medical advice before using Navir-4.

Primary Ingredients of Vmijam-MD4 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Vmijam-MD4 Tablet

Managing Nausea and Emesis

Major Benefits of Vmijam-MD4 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vmijam-MD4 Tablets. Avoid handling the tablets with damp hands. Place the tablet in your mouth, allowing it to dissolve, but refrain from swallowing it immediately. Vmijam-MD4 Tablets can be administered with or without food; however, consistent timing is recommended.

Common Side effects of Vmijam-MD4 Tablet:

  • Fatigue
  • Headache
  • Constipation
  • Diarrhea

How to use Vmijam-MD4 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vmijam-MD4 Tablets. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Vmijam-MD4 Tablets can be administered with or without food, although consistent timing is recommended.

How Vmijam-MD4 Tablet works:

Navoban-4 is an anti-vomiting drug. Its mechanism involves inhibiting serotonin, a neurotransmitter in the brain that can trigger nausea and vomiting associated with cancer therapy (chemotherapy) or post-operative recovery.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Using Vmijam-MD4 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Vmijam-MD4 Tablet usage in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Vmijam-MD4 Tablet while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Vmijam-MD4 Tablet on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Vmijam-MD4 Tablet poses no known safety risk to patients with kidney conditions; dosage modification isn't necessary. Nevertheless, disclose any pre-existing kidney disease to your physician. Data on the drug's use beyond a single day is currently limited.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Vmijam-MD4 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Vmijam-MD4 Tablet :

Should you forget a Vmijam-MD4 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vmijam-MD4 Tablet

LabelValue
Chemical Classification Carbazole-based compound
Developing Habits No.
Type of Therapy Gastrointestinal system

FAQs on Vmijam-MD4 Tablet

Vmijam-MD4 Tablet takes effect within 30 minutes to 2 hours, rapidly dissolving and becoming active in the bloodstream.
Vmijam-MD4 Tablet may cause constipation, diarrhea, fatigue, or headache. These side effects are typically mild and self-limiting. However, consult your doctor if they persist or are concerning.
Take Vmijam-MD4 Tablet with a full glass of water, regardless of food intake. Follow your doctor's prescribed dosage and duration precisely. Typically, the initial dose is administered before surgery, chemotherapy, or radiation therapy begins.
Vmijam-MD4 Tablet is a selective 5-HT3 receptor antagonist, an antiemetic medication, not a steroid. It's used to prevent and treat nausea and vomiting associated with surgery or cancer chemotherapy.
Vmijam-MD4 Tablets are ineffective for seasickness due to their minimal impact on motion sickness-related nausea.
Vmijam-MD4 Tablet
78
MRP 90
13% off